Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo
Abstract We aimed to identify potent biliverdin reductase (BVRA) inhibitors as a novel concept for the treatment of severe unconjugated hyperbilirubinemia. 1280 FDA-approved compounds were screened in vitro for their ability to inhibit human and rat BVRA activity and 26 compounds were identified a...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2017
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/d12f4548a8564f6a914ed21b89937903 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|